Related Experiment Video
Updated: Nov 29, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Rapidly progressive organizing pneumonia associated with COVID-19
Hiroshi Horii1, Keisuke Kamada1, Sho Nakakubo1
1Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, North 15 West 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
This case study highlights secondary organizing pneumonia (SOP) in a COVID-19 patient. Corticosteroid treatment improved respiratory failure, suggesting its benefit for COVID-19-associated lung complications.
Area of Science:
- Pulmonology
- Infectious Diseases
- Radiology
Background:
- Coronavirus disease 2019 (COVID-19) can lead to various pulmonary complications.
- Secondary organizing pneumonia (SOP) is a potential, though less common, manifestation requiring clinical awareness.
Observation:
- A 70-year-old female COVID-19 patient developed rapid respiratory failure despite initial symptom improvement.
- Computed tomography revealed bilateral lung consolidation, indicating severe lung injury.
- Blood biomarkers Krebs von den Lungen-6 (KL-6) and surfactant protein D (SP-D) exhibited distinct patterns during the disease course.
Findings:
- Corticosteroid therapy led to significant improvement in dyspnea, oxygenation, and radiological findings.
- Serial monitoring of KL-6 and SP-D may aid in diagnosing and managing COVID-19-associated organizing pneumonia (OP).
Implications:
- Clinicians must consider SOP as a complication of COVID-19.
- Early recognition and corticosteroid treatment can be beneficial for patients with COVID-19-associated SOP.
- Further research into the role of biomarkers like KL-6 and SP-D in COVID-19 lung disease is warranted.
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

